Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® MRSA specialty page provides MRSA-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


The Growing Burden of ABSSSI
Bruce Jones, PharmD, BCPS, discusses the growing burden of ABSSSI and why there have been an influx of MRSA cases.
Trends of ABSSSI Incidence in the Community
Christian Sandrock, MD, MPH, FCCP, discusses the trends of acute bacterial skin and skin structure infections incidence and the increasing number of methicillin-resistant Staphylococcus aureus infections in the community.
Treatment Challenges Remain as ABSSSI Incidence Continues to Grow
Yoav Golan, MD, discusses trends in the incidence of acute bacterial skin and skin structure infections, standard protocols for treatment, and the challenges clinicians continue to face.
ABSSSI: Standard Protocol of Admission and Treatment
Panelists share the typical presentation of an acute bacterial skin and skin structure infection patient in the emergency department and the standard protocol of IV antibiotics.
What Makes Eravacycline a Unique Antibiotic?
Patrick Horn, MD, PhD, explains why eravacycline is a unique antibiotic and how it stands up against many different types of pathogens, including those that are multidrug-resistant.
Who is Not a Good Candidate for MRSA Prodrug TXA709?
Daniel Pilch, PhD, explains which patients would not make good candidates for MRSA prodrug TXA709.
Developing New Antibiotics: What's the Best Approach to Take?
Daniel Pilch, PhD, discusses the approach that he and his team took to develop a new drug to fight MRSA.
What Are the Special Properties of MRSA Prodrug TXA709?
Edmond LaVoie, PhD, describes the properties of prodrug TXA709.
Big advances in treatment can